Spectral AI, Inc. (MDAI)

Market Cap	76.38M +139.2%
Revenue (ttm)	16.93M -43.5%
Net Income	-13.88M
EPS	-0.48
Shares Out	31.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	700,404
Open	2.310
Previous Close	2.370
Day's Range	2.250 - 2.460
52-Week Range	1.180 - 3.210
Beta	1.16
Analysts	Strong Buy
Price Target	5.00 (+108.33%)
Earnings Date	May 12, 2026

About MDAI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed deci...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 65
• Stock Exchange: NASDAQ
• Ticker Symbol: MDAI
• Website: https://www.spectral-ai.com

Financial Performance

In 2025, Spectral AI's revenue was $19.65 million, a decrease of -33.57% compared to the previous year's $29.58 million. Losses were -$7.57 million, -50.05% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for MDAI stock is "Strong Buy." The 12-month stock price target is $5.0, which is an increase of 108.33% from the latest price.

Price Target

$5.0

(108.33% upside)

Analyst Consensus: Strong Buy